|
|
Production and Market of Docosahexaenoic Acid (DHA) in China - The second edition |
|
Request for Sample Pages |
| Published Date : 6 January 2012 |
|
|
|
Pages : 58 |
|
| |
|
|
|
|
|
|
|
DHA has attracted more and more attention since it has been recommended by the World Health Organization in 1993. There are two kinds of DHA in China, microalgal DHA and fish oil DHA. In the past five years, the development of fish oil DHA has been relatively stable, while microalgal DHA has witnessed a rapid growth. In 2011, China's output of fish oil is estimated at about 11,800 tonnes and microalgal DHA's would reach about 560 tonnes.
However, fish supply for DHA production is limited and China’s production technology is inefficient. What will be the future development trend of the industry? What is the actual situation of Chinese producers? How about related laws and regulations promulgated by Chinese government?
The demand for DHA in China becomes icreasingly large, so does the market size. The demand mainly comes from health care products and formula foods, the total DHA consumption of which may account for about 90% of the total DHA consumption in China. These two industries have been developing quickly in the past five years. What is the real consumption situation of DHA in these industries? And what is the demand trend in China’s DHA market?
To figure out these questions, CCM International carries out a deep investigation into China’s DHA industry and the following issues will be included in this report.
- Production situation (2009-2011)
- Industry environment
- Price change (2009-2011)
- Related laws and regulations
- Consumption volume evolution (2009-2011)
- Consumption pattern (2010-2011)
- Forecast on supply and demand (2012-2016)
|
|
|
|
Table of Contents : |
Introduction and methodology
1 Overview of DHA industry in China
1.1 Brief introduction to DHA
1.2 Industry environment in China
1.2.1 Global status of omega-3 industry
1.2.2 Economic environment
1.2.3 Policies and regulations
2 Production situation of DHA in China
2.1 Current production situation of DHA
2.1.1 Production situation of DHA, 2009-2011
2.1.1.1 Production situation of fish oil DHA, 2009-2011
2.1.1.2 Production situation of microalgal DHA, 2009-2011
2.1.2 Major producers and distributors
2.1.2.1 Major producers
2.1.2.2 Major distributors
2.2 Price
2.3 Raw material supply
2.4 Technology
2.4.1 Introduction to production technology
2.4.2 Comparison between different production technologies
3 Consumption of DHA in China
3.1 Overview of DHA consumption
3.1.1 Market size
3.1.2 Consumption pattern
3.1.3 DHA consumption in major end-use segments (separated by fish oil and microalgae)
3.1.4 Comparison of consumption habit between China and abroad
3.2 DHA consumption in major end-use segments
3.2.1 Formula foods
3.2.1.1 Market size
3.2.1.2 Consumers
3.2.1.3 Development trends
3.2.2 Health care products
3.2.2.1 Market size
3.2.2.2 Consumers
3.2.2.3 Development trends
3.2.3 Others
4 Forecast on DHA in the next five years in China
4.1 Influencing factors
4.1.1 Drivers
4.1.2 Barriers
4.2 Forecast on DHA's supply and demand in China
5 Conclusion
6 Profiles 44
6.1 Roquette Biotech Nutritionals (Wuhan) Co., Ltd. 44
...
6.14 Shandong Yuwang Pharmaceutical Company
LIST OF TABLES
Table 1.1-1 Properties of DHA
Table 1.2.3-1 Standards of DHA quality in China, 2000-2011
Table 1.2.3-2 Regulations on DHA industry in China since 2009
Table 1.2.3-3 Usage of DHA according to regulations, 2007-2010
Table 2.1.2.1-1 Major producers of fish oil for human in China, 2011
Table 2.1.2.1-2 Capacity and output of major producers of fish oil for human in China, 2009-2011
Table 2.1.2.1-3 Major producers of feed grade fish oil in China, 2011, tonne
Table 2.1.2.1-4 Major producers of microalgal DHA in China, 2011
Table 2.1.2.1-5 Capacity and output of major microalgal DHA oil producers in China, 2009-2011
Table 2.1.2.1-6 Potential microalgal DHA oil producers in China, 2011
Table 2.1.2.1-7 Major producers exclusively making DHA powder in China, 2011
Table 2.1.2.1-8 Capacity and output of major producers exclusively making DHA powder in China, 2009-2011
Table 2.1.2.2-1 Some DHA distributors in China, 2011
Table 2.2-1 Ex-work price of fish oil in China, Dec. 2011, USD/t
Table 2.2-2 Ex-work price of microalgal DHA in China, Dec. 2011
Table 2.3-1 Strains used by some Chinese producers to produce microalgal DHA oil, 2011
Table 3.1.2-1 DHA's consumption in different application fields in China, 2010-2011, tonne
Table 3.1.3-1 Consumption of microalgal DHA and fish oil DHA in different application fields in China, 2011, tonne
Table 3.2.1.2-1 Some major infant formula producers' consumption of DHA in China, 2010, tonne
Table 3.2.1.2-2 Some major infant cereal producers' consumption of DHA in China, 2010, tonne
LIST OF FIGURES
Figure 1.1-1 Molecular structure of DHA
Figure 1.2.2-1 GDP growth in China, 2006-Q3 2011
Figure 2.1.1.1-1 Capacity and output of fish oil for human in China, 2009-2011
Figure 2.1.1.2-1 Capacity and output of microalgal DHA in China, 2009-2011
Figure 2.1.2.1-1 Microalgal DHA oil production distribution by capacity in China, 2011
Figure 2.2-1 Ex-work price of ethyl ester fish oil in China, 2009-2011
Figure 2.2-2 Ex-work price of microalgal DHA powder in China, 2006-Dec. 2011
Figure 2.3-1 Output of fish oil in the world, 2007-2010
Figure 2.4.1-1 Flowchart of fish oil extraction method
Figure 2.4.1-2 Flowchart of method for producing ethyl ester fish oil
Figure 2.4.1-3 Flowchart of method for producing triglyceride fish oil
Figure 2.4.1-4 Flowchart of molecular distillation method
Figure 2.4.1-5 Flowchart of microbial fermentation method
Figure 3.1.1-1 Market size of DHA for human in China, by value, 2009-2011
Figure 3.1.1-2 Consumption volume of DHA for human in China, 2009-2011
Figure 3.1.2-1 Consumption pattern of DHA by volume in China, 2011
Figure 3.1.3-1 Consumption pattern of microalgal DHA by volume in China, 2011
Figure 3.1.3-2 Consumption pattern of fish oil DHA by volume in China, 2011
Figure 3.2.1.1-1 Consumption of DHA in infant formula in China, 2007-2011
Figure 3.2.1.1-2 Output of infant formula in China, 2007-2011
Figure 3.2.2.1-1 Consumption of DHA in health care products in China, 2007-2011
Figure 3.2.2.1-2 Output value of health care products in China, 2006-2010
Figure 4.2-1 Projected capacity and output of microalgal DHA in China, 2012-2016
Figure 4.2-2 Projected capacity and output of fish oil for human in China, 2012-2016
Figure 4.2-3 Projected demand for DHA in China, 2012-2016
Companies mentioned:
Guangdong Runke Bioengineering Co., Ltd., Hubei Fuxing Biotechnology Co., Ltd., Hunan Gago Biotechnology Co., Ltd., Inner Mongolia Yili Industrial Group Co., Ltd., Hangzhou Beingmate Group Co., Ltd., Nanjing Senhai Biological Oil and Fat Co., Ltd., Wuxi Xunda Marine Biological Products Co., Ltd., Shandong Hongyangshen Aquatic Technological (Group) Co., Ltd., Zhejiang Shenzhou Marine Bio-tech Co., Ltd.
|
|
|
|
Published By : CCM International Ltd |
|
|
Category
Related Report:
Automotive,
Automobile,
Aerospace & Aviation,
Banking,
Consumer Goods,
Construction,
Chemicals,
Defense,
Diabetes,
Disease,
Drinks,
Energy,
Electronics,
Financial
,
Food & Drinks,
Glass,
Healthcare,
Insurance,
Information technology,
Investment,
Industrial Gases,
Industry Profile,
Medical,
Media,
Marketing,
Miscellaneous,
Metals & Mining,
Nuclear Energy,
Oil & Gas,
Power,
Real Estate,
Software,
Solar,
Transportation
|
|
|
|
